Literature DB >> 3930128

Effects of physiological concentrations of vasopressin on haemostatic function in man.

P J Grant, J A Davies, G M Tate, M Boothby, C R Prentice.   

Abstract

Plasma concentrations of vasopressin (aVP) attained under conditions of stress were simulated by infusing four volunteers with 0.25, 0.5, 1.0 and 2.0 pressor units of aVP over 1 h (units/h). Three subjects had all four infusions and one received only 1.0 unit/h. Blood samples were taken for assay of factor VIII coagulant activity (FVIIIC), factor VIII related antigen (FVIIIRAg), the ristocetin cofactor (FVIIIRiCof), euglobulin lysis time (ELT) and aVP concentrations before infusion (time 0) and every 20 min for 80 min. Fibrinopeptide A (FPA) generation time was measured at time 0, 60 and 80 min. At infusion rates of 0.25 unit/h median aVP levels peaked at 6.5 pg/ml and there was no change in FVIII or FPA generation time, and plasminogen activator activity (10(6)/ELT2) rose from 100 to 400 units. At 1.0 unit/h, aVP levels rose to 25.4 pg/ml, FVIIIC rose by 160% and activator activity from 87 to 360 units. At 2.0 units/h, aVP concentrations reached 83 pg/ml, there was an increase in all modalities of FVIII and activator activity rose from 251 to 452 units. FPA generation time shortened and circulating plasma levels of FPA were increased. There was a highly significant correlation between the percentage increases in all three components of FVIII and plasma aVP levels (FVIIIC: r = 0.87, P less than 0.0001; FVIIIRAg: r = 0.61, P less than 0.0001; FVIIIRiCof: r = 0.80, P less than 0.0001) and between the increase in plasminogen activator activity and aVP levels (r = 0.56, P less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930128     DOI: 10.1042/cs0690471

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  Letter from Chicago: Lives for votes.

Authors:  G Dunea
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-08

2.  Combined use of vasopressin and synthetic hypothalamic releasing factors as a new test of anterior pituitary function.

Authors:  P J Grant; P G Wiles; J A Davies; C R Prentice
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-29

3.  Vasopressin and diabetic ketoacidosis.

Authors:  P J Grant; P G Wiles; J A Davies; C R Prentice
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

4.  Proceedings of the British Thoracic Society. 1988 summer meeting. 13-15 July, Newcastle upon Tyne. Abstracts.

Authors: 
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

5.  Vasopressin stimulates the proliferation and differentiation of red blood cell precursors and improves recovery from anemia.

Authors:  Balázs Mayer; Krisztián Németh; Miklós Krepuska; Vamsee D Myneni; Dragan Maric; John F Tisdale; Matthew M Hsieh; Naoya Uchida; Heon-Jin Lee; Michael J Nemeth; Kenn Holmbeck; Constance Tom Noguchi; Heather Rogers; Soumyadeep Dey; Arne Hansen; Jeffrey Hong; Ian Chow; Sharon Key; Ildikó Szalayova; Jerome Pagani; Károly Markó; Ian McClain-Caldwell; Lynn Vitale-Cross; W Scott Young; Michael J Brownstein; Éva Mezey
Journal:  Sci Transl Med       Date:  2017-11-29       Impact factor: 17.956

6.  Secretion of von Willebrand factor by endothelial cells links sodium to hypercoagulability and thrombosis.

Authors:  Natalia I Dmitrieva; Maurice B Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.